Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing

Conditions:   Opioid Use Disorder;   Opioid Withdrawal Intervention:   Drug: Buprenorphine/naloxone Sponsors:   United Health Services Hospitals, Inc.;   Binghamton University Not yet recruiting

Source: ClinicalTrials.gov - April 1, 2022 Category: Research Source Type: clinical trials